ALLERGAN SAUDI LLC CELEBRATING EXPANSION AND COMMITMENT TO KSA WITH NEW ENTITY INAUGURAL

With its continuous efforts to improve the level of healthcare services in KSA, Allergan, a leading global pharmaceutical company (Allergan PLC), in partnership with Cigalah Group, a leader in pharmaceutical business in Saudi, celebrated the inauguration of their newly established entity Allergan Saudi LLC on 8th March 2017. 150 attendees joined the occasion including dignitaries from KSA, representatives from healthcare authorities and governmental officials from MOH, SFDA, SAGIA, Chamber of Commerce and Labor Office.

Commenting on the event, Ismail Bakr, Country manager of Allergan Saudi LLC said: “We’re very proud of the new presence of Allergan in KSA. Our expansion, announced today is testimony to our commitment to healthcare professionals and their patients within KSA. Allergan Saudi LLC is a multi-specialty healthcare company focused on developing and commercializing innovative branded pharmaceuticals, devices and biologic products. Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.”

Allergan’s strategic vision is in alignment with the Kingdom’s Vision 2030 “Vibrant Society, Thriving Economy, Ambitious Nation” initiated by the Custodian of the Two Holy Mosques King Salman Bin Abdul Aziz and the Deputy Crown Prince Mohammed Bin Salman. Vision 2030 was established to encourage foreign investments particularly for multinational companies such as Allergan. With Allergan’s commitment to medical education and major knowledge-based contributions in the medical sector, Saudi Arabia can expect to generate inspiring outcomes in the near future.
It is worth mentioning that Allergan PLC (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. It is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the globe. Allergan markets a portfolio of best-in-class products for eye care, medical aesthetics and dermatology, gastroenterology, central nervous system, urology and anti-infective therapeutic categories and women's health. With commercial operations in about 100 countries, Allergan’s success is powered by more than 16,000 employees’ committed to being Bold for Life.